期刊文献+

4-(苯并咪(噻)唑2-)苯甲脒类化合物的合成及其一氧化氮合酶抑制活性 被引量:1

Synthesis and NOS Inhibitory Activity of 4-(Benzimidazole(or Benzoth iazole)-2-yl)-Benzamidine Compounds
下载PDF
导出
摘要 目的 :寻找抑制一氧化氮合酶 (NOS)并对相关疾病具有较好治疗作用的化合物。方法 :以苯甲脒为基本母核 ,在苯环的对位引入 2 苯并咪 (噻 )唑基 ,然后在脒基N上引入环状或非环状的取代基 ,并测定目标化合物的诱生型NOS(iNOS)抑制活性。结果和结论 :合成了 4 (苯并咪 (噻 )唑 2 )苯甲脒类化合物 12个 ,其结构经IR、1 HNMR、MS和元素分析确证。初步的药理试验表明目标化合物具有不同程度的iNOS抑制活性 ,神经型NOS(nNOS) AIM:To search for novel potent compounds with NOS inhibitory activity for the treatment of the related diseases METHOD:2-be nzimidazole or 2 -benzothiazole groups were introduced into the p-position of benzamidine,the n t he H on the amidines was substituted by alkyl,and the iNOS inhibitory activity of the target compounds were measured RESULT AND CONCLUSION:Seven 4-(benzimidazo le-2-yl)-benzamidine compounds(Ⅰ-1~7) and five 4-(benzothiazole-2 -yl)-benzami dine compounds(Ⅰ-8~12) were synthesized,and their structures were confir med b y 1HNMR,MS,IR spectra and elementary analysis The results of preli minary ph armacological test showed that the compounds had iNOS inhibitory activity,and t he test of nNOS inhibitory activity is under way
出处 《中国药科大学学报》 CAS CSCD 北大核心 2004年第1期12-15,共4页 Journal of China Pharmaceutical University
关键词 NOS抑制剂 苯甲脒 合成 NOS inhibitor Benzamidine Synthesis
  • 相关文献

参考文献1

二级参考文献12

  • 1Cad X, Scannell RT, Yaeger D,et al.Trans-2-[3-Methoxy-4-chlorophenylthio- ethoxy-5-( N- methyl- N- hydroxyureidyl )methylphenyl]-5-( 3, 4,5-trimethoxyphe-nyl)tetrahydrofuran(CMI-392), a potent dual 5-1ipoxygenase inhibitor and platelet-activating factor receptor antagonist[J].J Med Chem,1998,41:1970-1979
  • 2Hussaini IM, Zhang YH, Lysiak JJ,et al. Dithiolane analogs of lignans inhibit interferon-γ and lipooplysaccharide-induced nitric oxide production in macrophages[J].Acta Pharmacol Sin, 2000,21:897-904.
  • 3Cai X,Arrington M,Bayless L,et al. Discovery of UCB35440: A potent and orally active dual acting 5-lipoxygenase inhibitor and H1 receptor antagonist.Abstracts of Papers[C]. Boston: 224^th National Meeting of the American Chemical Society,2002.
  • 4Alabaster VA, Moore BA. New perspectives on basic mechanisms in lung disease. Drug intervention in asthma: present and future[ J ].Thorax, 1993,48:176-182.
  • 5McCartey-Francis N, Allen JN, Mizel DE, et al. Suppressien of arthritis by an inhibiter of nitric oxide synthase[ J ]. J Exp Med,1993,178: 749-753.
  • 6Thiemermann C.Selective inhibition of the activity of inducible nitric oxide synthase in septic shock[J].Prog Clin Biol Res,1995,392:383-392
  • 7Southan GJ,Szabo C.Selective pharmacological inhibition of distinct nitric oxide synthase isoforms[J].Biochem Pharmacol,1996,51:383-394
  • 8Hussoin MS, Yeh CG. The design of dual-acting compounds with PAF receptor antagoristic and 5-lipoxygenase inhibitory activities[ J ].Drugs Fut, 1996,21:933-944.
  • 9Szaho C, Wu CC, Mitchell JA,et al.Platelet-activating factor contributes to the induction of nitric oxide synthase by bacterial lipopolysaceharide[J]. Cir Res, 1993,73:991-999.
  • 10Arthur .IF, Shahin S, Dusting GJ. PAF antagonists block induction of nitric oxide synthase in cultured and macrophage and vascular smooth muscle cells[J].Clin Exptl Pharmacol Physiol,1995,22:452-454

共引文献1

同被引文献18

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部